Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Gene Silencing/Gene Editing » Sirna Files IND for RNAi-based AMD Drug

Sirna Files IND for RNAi-based AMD Drug

Sep 10, 2004
Premium

Sirna Therapeutics announced this week that it has filed an investigational new drug application to begin clinically testing an RNAi-based treatment for age-related macular degeneration, making it the second company to have done so.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Treatment for Rapid Aging

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

AstraZeneca, Oxford Announce Results Suggesting High Efficacy of Vaccine

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

Criticism Leads to Review of Paper

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

PLOS Papers on SARS-CoV-2 Phylogenies, Swiss Influenza Spread, Infant Meningitis in Ethiopia

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.

Dec
03
Featured Webinar

Leveraging Multi-Omic Approaches to Understand Disease Stem Cells in Myeloid Malignancies

Sponsored by
Mission Bio

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion. 

Dec
10
Featured Webinar

Accelerating Forward Engineering and Genome Discovery with CRISPR: E. Coli Case Studies

Sponsored by
Tecan

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology. 

What's Popular?

In Gene Silencing/Gene Editing

  1. FNIH Panel on Gene Drive Regulation Emphasizes Need for Local Community Engagement

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.